AAAAAA

   
Results: 1-10 |
Results: 10
Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995
Authors: Jefferies, LC Sachais, BS Young, DS
Citation: Lc. Jefferies et al., Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995, TRANSFUSION, 41(4), 2001, pp. 522-529
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through Fc gamma RIIA
Authors: Reilly, MP Taylor, SM Hartman, NK Arepally, GM Sachais, BS Cines, DB Poncz, M McKenzie, SE
Citation: Mp. Reilly et al., Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through Fc gamma RIIA, BLOOD, 98(8), 2001, pp. 2442-2447
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
Authors: Guo, YJ Higazi, AA Arakelian, A Sachais, BS Cines, D Goldfarb, RH Jones, TR Kwaan, H Mazar, AP Rabbani, SA
Citation: Yj. Guo et al., A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo, FASEB J, 14(10), 2000, pp. 1400-1410
Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo
Authors: Haj-Yehia, A Nassar, T Sachais, BS Kuo, A Bdeir, K Al-Mehdi, AB Mazar, A Cines, DB Higazi, AA
Citation: A. Haj-yehia et al., Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo, FASEB J, 14(10), 2000, pp. 1411-1422
A region in domain II of the urokinase receptor required for urokinase binding
Authors: Bdeir, K Kuo, A Mazar, A Sachais, BS Xiao, WZ Gawlak, S Harris, S Higazi, A Cines, DB
Citation: K. Bdeir et al., A region in domain II of the urokinase receptor required for urokinase binding, J BIOL CHEM, 275(37), 2000, pp. 28532-28538
The costs of disease
Authors: Young, DS Sachais, BS Jefferies, LC
Citation: Ds. Young et al., The costs of disease, CLIN CHEM, 46(7), 2000, pp. 955-966
Laboratory costs in the context of disease
Authors: Young, DS Sachais, BS Jefferies, LC
Citation: Ds. Young et al., Laboratory costs in the context of disease, CLIN CHEM, 46(7), 2000, pp. 967-975
The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis
Authors: Higazi, AA Nassar, T Ganz, T Rader, DJ Udassin, R Bdeir, K Hiss, E Sachais, BS Williams, KJ Leitersdorf, E Cines, DB
Citation: Aa. Higazi et al., The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis, BLOOD, 96(4), 2000, pp. 1393-1398
Defensin promotes the binding of lipoprotein(a) to vascular matrix
Authors: Bdeir, K Cane, W Canziani, G Chaiken, I Weisel, J Koschinsky, ML Lawn, RM Bannerman, PG Sachais, BS Kuo, A Hancock, MA Tomaszewski, J Raghunath, PN Ganz, T Higazi, AAR Cines, DB
Citation: K. Bdeir et al., Defensin promotes the binding of lipoprotein(a) to vascular matrix, BLOOD, 94(6), 1999, pp. 2007-2019
Novel pncA mutations in pyrazinamide-resistant isolates of Mycobacterium tuberculosis
Authors: Sachais, BS Nachamkin, I Mills, JK Leonard, DGB
Citation: Bs. Sachais et al., Novel pncA mutations in pyrazinamide-resistant isolates of Mycobacterium tuberculosis, MOL DIAGN, 3(4), 1998, pp. 229-232
Risultati: 1-10 |